New CGM system aims to personalize diabetes management
NCT ID NCT04443153
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a continuous glucose monitor (CGM)-based advisory system to help adults with type 1 diabetes better manage their blood sugar. The system gives personalized advice based on glucose readings and the person's behavior and mindset. The goal was to improve glucose control and reduce the mental burden of diabetes management.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Virginia Center for Diabetes Technology
Charlottesville, Virginia, 22903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Can a peptide tame type 1 diabetes?
- Can a tiny implant track glucose, ketones, and lactate in diabetes?
- Wearable sensor could unmask hidden blood sugar chaos in stomach paralysis
- A smarter insulin that aims for the liver could curb dangerous nighttime dips
- Smart insulin pump may boost brain and body health in older adults with diabetes